Mirtazapine for Sleep and Appetite Recovery After a Serious Injury

James Wong — Founder & Pharmacist, LienScripts | March 13, 2025 | 7 min read

Mirtazapine (Remeron) is prescribed after serious injury for its powerful sedative and appetite-stimulating effects, alongside its full antidepressant activity. For patients who have lost significant weight and cannot sleep following major trauma, mirtazapine addresses multiple injury consequences simultaneously.

What Is Mirtazapine?

Mirtazapine (brand name Remeron) is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). Its mechanism of action differs from both SSRIs and SNRIs — rather than blocking reuptake of monoamines, it works primarily by blocking presynaptic alpha-2 adrenergic receptors (which increases norepinephrine and serotonin release) and by blocking specific serotonin receptor subtypes (5-HT2 and 5-HT3).

This distinct pharmacological profile produces three therapeutically useful effects in personal injury patients:

1. Powerful sedation — particularly at low doses, driven by potent H1 histamine receptor blockade
2. Appetite stimulation — mediated by 5-HT2C and H1 receptor blockade, which increases appetite and caloric intake
3. Full antidepressant activity — at higher doses, mirtazapine is as effective as SSRIs and SNRIs for major depressive disorder

It is this combination of effects that makes mirtazapine particularly well-suited to seriously injured patients, who commonly present with all three problems — sleep disruption, appetite loss, and depression — simultaneously.

[!KEY] A mirtazapine prescription in the PI record signals that the physician assessed the patient as having clinically significant sleep disruption, appetite loss, or depression — and the dose prescribed indicates which problem was the primary clinical target.

Sleep Disruption and the Sedative Properties of Mirtazapine

Why Mirtazapine Works Differently Than Other Sleep Medications

Trazodone, described in a related post, is the most commonly prescribed medication for post-injury insomnia because it is effective, non-habit-forming, and fast-acting. But for patients with more severe or refractory sleep disruption, mirtazapine is often more powerful.

Mirtazapine's sedative effect comes primarily from its potent blockade of histamine H1 receptors — the same receptor targeted by diphenhydramine (Benadryl), but with substantially higher affinity and a more sustained effect.

The Paradoxical Dose-Effect Relationship

Mirtazapine has a counterintuitive dosing relationship with sedation: at lower doses (7.5–15 mg), the sedative effect is maximal. At higher doses (30–45 mg), the sedation is actually less pronounced. This paradox arises because at higher doses, mirtazapine also activates noradrenergic pathways that produce a stimulating, activating effect — partially counteracting the H1 sedation.

For sleep, this means:

• 7.5 mg at bedtime — maximum sedation, minimal antidepressant effect
• 15 mg at bedtime — strong sedation, beginning antidepressant effect
• 30–45 mg at bedtime — full antidepressant effect, moderate sedation

Physicians managing a seriously injured patient who primarily needs sleep may prescribe 7.5–15 mg. If depression is the dominant concern, 30–45 mg is the therapeutic range. The dose the patient is prescribed tells the clinical story of which problem the physician is primarily targeting.

Appetite Loss and Weight Loss After Serious Injury

The Clinical Reality of Post-Injury Malnutrition

Seriously injured patients — particularly those with orthopedic injuries requiring significant bed rest, burn injuries, spinal injuries, or major surgical recovery — frequently experience dramatic weight loss. The mechanisms are multiple:

• Pain and nausea reduce appetite directly
• Hypermetabolic state from severe injury increases caloric requirements while appetite decreases
• Depression and anxiety further suppress appetite
• Medications (opioids, muscle relaxants, antibiotics) can cause nausea and reduced appetite as side effects

The result is that patients often enter a period of significant nutritional deficit at precisely the moment when their bodies require maximum nutritional support for healing.

Mirtazapine's Appetite-Stimulating Effect

Mirtazapine's blockade of serotonin 5-HT2C receptors and histamine H1 receptors directly increases appetite and food intake. In clinical practice, weight gain is well-documented as a side effect of mirtazapine — but in the setting of post-injury weight loss, this effect is therapeutically beneficial rather than a problem.

A patient who lost significant weight during the acute phase of a serious injury and then gained it back during mirtazapine therapy has a medical record that tells a clear story: the injury was severe enough to produce measurable weight loss, the weight loss was clinically significant enough to require pharmacological intervention, and recovery of nutritional status was achieved with appropriate treatment.

This trajectory — weight loss documented in medical records, mirtazapine prescribed, weight recovery tracked at follow-up appointments — provides meaningful documentation of the severity of the injury's impact on the patient's physical health.

Depression After Serious Injury

Mirtazapine is a full antidepressant at therapeutic doses (30–45 mg/day), comparable in efficacy to SSRIs and SNRIs in controlled trials. For seriously injured patients who develop major depressive disorder during their recovery — which is common, particularly in cases involving prolonged disability, significant functional limitation, or disfiguring injuries — mirtazapine may be selected specifically because of its combined benefit for depression, sleep, and appetite.

A physician who prescribes mirtazapine for a seriously injured patient is making a clinical assessment that the patient has multiple significant problems — all caused or worsened by the injury — that this single medication can meaningfully address. The prescribing decision itself reflects the complexity and severity of the patient's clinical picture.

Mirtazapine vs. Trazodone for Sleep in PI Cases

Both trazodone and mirtazapine are commonly prescribed for post-injury sleep disruption, and both are appropriate non-habit-forming alternatives to benzodiazepines. The clinical distinction:

• Trazodone is typically the first choice for uncomplicated post-injury insomnia — it works quickly, has a well-established safety record, and is available as an inexpensive generic
• Mirtazapine is more appropriate when the patient has significant sleep disruption in combination with appetite loss or depression, when trazodone has not provided adequate sleep benefit, or when the patient's clinical picture includes weight loss that needs to be addressed

An escalation from trazodone to mirtazapine — or concurrent use of both for different purposes — documents the progressive complexity of the patient's sleep and mood problems.

[!KEY] When a prescriber escalates from trazodone to mirtazapine for sleep, that escalation documents treatment failure with first-line therapy — a clinical event that is difficult for defense to dismiss and that supports a more serious portrayal of the patient's post-injury sleep disorder.

[!NOTE] Weight loss documented before the mirtazapine prescription, and weight recovery tracked at follow-up appointments during treatment, quantifies the physical impact of the injury in the medical record in a way that verbal reports cannot.

PI Case Documentation Value

For both patients and attorneys, mirtazapine in the pharmacy record carries meaningful information:

• A mirtazapine prescription signals that the treating physician assessed the patient as having clinically significant sleep disruption, appetite loss, or depression — not merely reporting minor discomfort
• The dose prescribed indicates which clinical problem was the primary target
• The weight data in the medical record surrounding the mirtazapine prescription — weight loss before, weight recovery during — quantifies the physical impact of the injury
• Long-term mirtazapine prescriptions (months of refills) document the duration of the patient's recovery struggle

Pharmacy Lien Coverage for Mirtazapine

Mirtazapine prescribed by a treating physician for post-injury sleep disruption, appetite loss, or depression is covered under a pharmacy lien with LienScripts. The medication is available as an inexpensive generic and is routinely included in pharmacy lien coverage for qualifying patients.

For seriously injured patients whose recovery involves the full clinical picture — sleep disruption, weight loss, depression — pharmacy lien coverage ensures that mirtazapine and all other treating medications are accessible from the first fill through final settlement, without requiring out-of-pocket expenditure the patient cannot afford during a period of financial disruption from their injury.

[!KEY] Mirtazapine's ability to address sleep disruption, appetite loss, and depression simultaneously makes it uniquely valuable PI documentation — a single prescription signals that the physician assessed all three injury consequences as clinically significant and requiring concurrent pharmacological treatment.

To learn how pharmacy lien coverage works, visit for patients.

Related Resources

• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?